Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm

Integration of risk factors to allow pat

Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients

✍ William C. Wood 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 645 KB

The selection of patients with axillary lymph node-negative breast cancer who should receive adjuvant therapy today is confused by an expanding arsenal of putative prognostic factors. The size of the primary tumor remains the dominant factor in sorting among this group of patients, with general agre